Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

Room 1.06
In programme
Thursday, 24 October, 2024 - 17:50 to 19:20
View presentations

About

This session covers several issues related to cannabis and synthetic cannabinoids, substance use treatment.

Chair

Placeholder Image
Gagnon
François
Senior scientist and special policy advisor
Canadian Center on Drug Use and Addiction

Type

Short communication session

Tracks

Drug policy: latest developments and new challenges

Keywords

Qualitative methods
Monitoring and evaluation
Treatment
Criminal justice/prisons
Criminology
Policy
Europe
Opiates
Drug user's perspectives
Underrepresented groups
Alcohol
Cannabis
Psychostimulants
Public health
Markets
Prevention
Quantitative methods
Recreational setting
Oceania
New psychoactive substances
Toxicology and forensic analysis

Presentations

Thursday, 24 October

17:50

Short communication

A comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study

17:50 to 19:20
Room 1.06
Nadine Heckel

Short communication

Managing the drug-driver: insights from Victoria’s large-scale roadside testing program

17:50 to 19:20
Room 1.06
Michael Fitzharris

Short communication

Metabolite profile of synthetic cannabinoids seized in Portugal

17:50 to 19:20
Room 1.06
Rita Padinha Lopes

Short communication

Project on fine default prisoners with substance abuse problems – preliminary findings of an evaluation and impact study

17:50 to 19:20
Room 1.06
Jukka Leinonen

Short communication

Recommendations from the government cannabis committee on the legal availability of vaping products.

17:50 to 19:20
Room 1.06
Robert Perreault

Short communication

The experience of aging among patients in opioid assisted treatment. A qualitative study.

17:50 to 19:20
Room 1.06
Siv-Elin Leirvåg Carlsen

Short communication

The impact of Cannabis market Regulation on adolescents in Uruguay

17:50 to 19:20
Room 1.06
Leticia Keuroglian
View the programme